Validating and improving models for projecting the absolute risk of breast cancer.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Journal of the National Cancer Institute

• Publication date

  2001-03-07

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/JNCI/93.5.334PMID 11238688
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention.

  2001cited by this paper
• Validation studies for models projecting the risk of invasive and total breast cancer incidence.

  1999cited by this paper
• Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer.

  1999cited by this paper
• Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.

  1999cited by this paper
• Risk-based recommendations for mammographic screening for women in their forties.

  1998cited by this paper
• Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women.

  1998cited by this paper
• The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.

  1997cited by this paper
• Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history.

  1997cited by this paper
• Nurses' health study: log-incidence mathematical model of breast cancer incidence.

  1996cited by this paper
• Cowden syndrome.

  1995cited by this paper
• Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study.

  1995cited by this paper
• Mammographic features and breast cancer risk: effects with time, age, and menopause status.

  1995cited by this paper
• Validation studies on a model for breast cancer risk.

  1994cited by this paper
• Autosomal dominant inheritance of early‐onset breast cancer. Implications for risk prediction

  1994cited by this paper
• Validation of the Gail et al. model for predicting individual breast cancer risk.

  1994cited by this paper
• Validation of a breast cancer risk assessment model in women with a positive family history.

  1994cited by this paper
• Epidemiology and Biostatistics Program of the National Cancer Institute

  1994cited by this paper
• Projecting individualized probabilities of developing breast cancer for white females who are being examined annually.

  1989cited by this paper
• Cancer Prevention

  1986cited by this paper

• Risk-Based Screening for Breast Cancer: Time to Focus on Implementation.

  2026cites this paper
• Breast cancer screening and prevention in the UAE: a cross-sectional study of risk awareness and provider engagement

  2025cites this paper
• Competing risks and multivariate outcomes in epidemiological and clinical trial research

  2024cites this paper
• NCCN Guidelines® Insights: Breast Cancer Screening and Diagnosis, Version 1.2023.

  2023cites this paper
• Accuracy of Perceived Breast Cancer Risk in Black and White Women with an Elevated Risk.

  2022cites this paper
• Prediction of breast cancer risk among women of the Mariana Islands: the BRISK retrospective case–control study

  2022cites this paper
• Understanding risk factors for cancer: What's new and how can it help reduce the cancer burden?

  2022cites this paper
• The Role of Exosomes in Breast Cancer Diagnosis

  2021influential citation
• Breast Cancer Screening and Diagnosis

  2020cites this paper
• Gail Model Improves the Diagnostic Performance of the Fifth Edition of Ultrasound BI-RADS for Predicting Breast Cancer: A Multicenter Prospective Study.

  2020cites this paper
• Breast cancer risk assessment and management programs: A practical guide

  2020cites this paper
• Evaluating the predictive performance of Malaria antibodies and FCGR3B 1 Gene Polymorphisms on Plasmodium falciparum infection outcome: a 2 prospective cohort study

  2019cites this paper
• A way forward for cancer prevention therapy: personalized risk assessment

  2019cites this paper
• Ultrasound for Breast Cancer Screening in High-Risk Women: Results From a Population-Based Cancer Screening Program in China

  2019cites this paper
• Evaluating the predictive performance of malaria antibodies and FCGR3B gene polymorphisms on Plasmodium falciparum infection outcome: a prospective cohort study

  2019cites this paper
• Predicting risk for adverse health events using random forest

  2018cites this paper
• Risk reducing surgery and treatment of menopausal symptoms in BRCA mutation carriers (and other risk women)

  2018cites this paper
• Risk Reduction Strategies in Breast Cancer Prevention.

  2017cites this paper
• Hereditary Lifetime Cancer Risk Assessment Modeling: A Case Study in Breast Cancer

  2017cites this paper
• Derivation and validation of German risk scores predicting substantial gain in weight and waist circumference

  2016cites this paper
• Benign Breast Diseases: Evaluation and Management.

  2016cites this paper
• Preventive and Risk Reduction Strategies for Women at High Risk of Developing Breast Cancer: a Review.

  2016cites this paper
• Effects of a risk-based online mammography intervention on accuracy of perceived risk and mammography intentions.

  2016cites this paper
• Mammography Exemplars in online News Commentary: Prevalence of Exemplars, Effects on Risk Perceptions and Mammography Intentions, and Mechanisms of Action

  2016cites this paper
• Using an epidemiological tool for medical and public health practice

  2016cites this paper
• A fully automated breast separation For mammographic images

  2015cites this paper
• Correcting for bias in the selection and validation of informative diagnostic tests

  2015cites this paper
• Breast Cancer Risk Reduction, Version 2.2015.

  2015cites this paper
• Breast Cancer Risk Reduction , Version 2 . 2015 Clinical Practice Guidelines in Oncology

  2015cites this paper
• Risk Classification With an Adaptive Naive Bayes Kernel Machine Model

  2015cites this paper
• Genetics of breast cancer: a topic in evolution.

  2015influential citation
• A fully automated breast separation For mammographic images

  2015cites this paper
• Gaining control over breast cancer risk: Transforming vulnerability, uncertainty, and the future through clinical trial participation - a qualitative study.

  2015cites this paper
• Chemoprevention or mastectomy for women at high risk of developing breast cancer.

  2015cites this paper
• A systematic assessment of benefits and risks to guide breast cancer screening decisions.

  2014cites this paper
• Can the Gail model increase the predictive value of a positive mammogram in a European population screening setting? Results from a Spanish cohort.

  2013cites this paper
• FISETIN, A FLAVONOID, INDUCES CELL CYCLE ARREST AND APOPTOSIS IN HUMAN BREAST CANCER CELLS

  2013cites this paper
• Testing for improvement in prediction model performance

  2013cites this paper
• A meta-analysis of pigmentary characteristics, sun sensitivity, freckling and melanocytic nevi and risk of basal cell carcinoma of the skin.

  2013cites this paper
• Using a state cancer registry to recruit young breast cancer survivors and high-risk relatives: protocol of a randomized trial testing the efficacy of a targeted versus a tailored intervention to increase breast cancer screening

  2013cites this paper
• Positive and negative affect, depression, and cognitive processes in the Cognition in the Study of Tamoxifen and Raloxifene (Co-STAR) Trial

  2013cites this paper
• A case-control study on risk factors of breast cancer in China

  2012cites this paper
• Representing randomness in the communication of individualized cancer risk estimates: effects on cancer risk perceptions, worry, and subjective uncertainty about risk.

  2012cites this paper
• The influence of health and lifestyle characteristics on the relation of serum 25-hydroxyvitamin D with risk of colorectal and breast cancer in postmenopausal women.

  2012cites this paper
• NCCN Breast Cancer Risk Reduction Panel Members Summary of the Guidelines Updates Clinical Trials : Categories of Evidence and Consensus :

  2012cites this paper
• Recommendations for raloxifene use in daily clinical practice in the Swiss setting

  2012cites this paper
• Mammographic density and breast cancer phenotypes

  2012cites this paper
• Inference and Prediction for High Dimensional Data via Penalized Regression and Kernel Machine Methods

  2012cites this paper
• Prediction, Communication, and Distribution of Breast Cancer Risk

  2012influential citation
• Raloxifene

  2012cites this paper
• Cancer Screening and Prevention

  2011cites this paper
• Relationship between breast sound speed and mammographic percent density

  2011cites this paper
• Magnetic Resonance Imaging (MRI) in the Screening of High-Risk Patients and in the Detection and Diagnosis of Early Breast Cancer

  2011cites this paper
• Practice of Epidemiology Problems With Risk Reclassification Methods for Evaluating Prediction Models

  2011cites this paper
• Computer Aided Risk Estimation of Breast Cancer

  2011cites this paper
• 5 Breast Imaging

  2011cites this paper
• Endocrine therapy of breast cancer.

  2011cites this paper
• A novel and automatic mammographic texture resemblance marker is an independent risk factor for breast cancer.

  2011cites this paper
• A Perturbation Method for Inference on Regularized Regression Estimates

  2011cites this paper
• Communication of Uncertainty Regarding Individualized Cancer Risk Estimates

  2011cites this paper
• SI RLTD: Risk Scores and Decision Making: The Anatomy of a Decision to Reduce Breast Cancer Risk.

  2010cites this paper
• Genetic/familial high-risk assessment: breast and ovarian.

  2010cites this paper
• NCCN Breast Cancer Risk Reduction Clinical Practice Guidelines in Oncology

  2010cites this paper
• Computer Aided Risk Estimation of Breast Cancer: The “Hippocrates-mst” Project

  2010cites this paper
• Identifying cost-effective treatment with raloxifene in postmenopausal women using risk algorithms for fractures and invasive breast cancer.

  2010cites this paper
• Breast Cancer Screening in Women at Average Risk and High Risk

  2010cites this paper
• Knowledge and Accuracy of Perceived Personal Risk in Underserved Women Who are at Increased Risk of Breast Cancer

  2010cites this paper
• Breast cancer risk reduction.

  2010cites this paper
• Preoperative Breast Evaluation in Women Seeking Cosmetic Breast Procedures: An Evidence-based Review

  2010cites this paper
• Why Some Women Have an Optimistic or a Pessimistic Bias About Their Breast Cancer Risk: Experiences, Heuristics, and Knowledge of Risk Factors

  2010cites this paper
• NCCN Clinical Practice Guidelines in Oncology for Breast Cancer Risk Reduction

  2010cites this paper
• Prevention of Breast Cancer (Part I): Epidemiology, Risk Factors, and Risk Assessment Tools

  2010cites this paper
• NCCN Breast Cancer Screening and Diagnosis Panel Members

  2010cites this paper
• Integration of Risk Assessment in Prostate Cancer Screening

  2009cites this paper
• Raloxifene use in clinical practice: efficacy and safety

  2009cites this paper
• Breast Cancer Screening and DiagnosisPractice Guidelines in Oncology TM

  2009cites this paper
• Effects of tamoxifen and raloxifene on memory and other cognitive abilities: cognition in the study of tamoxifen and raloxifene.

  2009cites this paper
• NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis.

  2009cites this paper
• Diffusion of Breast Cancer Risk Assessment in Primary Care

  2009cites this paper
• Laypersons' Responses to the Communication of Uncertainty Regarding Cancer Risk Estimates

  2009cites this paper
• Underestimation of breast cancer risk: influence on screening behavior.

  2009cites this paper
• The NSABP Study of Tamoxifen and Raloxifene (STAR) trial

  2009cites this paper
• Economic evaluation of chemoprevention of breast cancer with tamoxifen and raloxifene among high-risk women in Japan

  2009cites this paper
• Retention of screened women in the Manitoba Breast Screening Program.

  2008cites this paper
• Managing the risk of invasive breast cancer in women at risk for breast cancer and osteoporosis: the role of raloxifene

  2008cites this paper
• Fractal analysis of mammographic parenchymal patterns in breast cancer risk assessment.

  2007cites this paper
• Personal care products that contain estrogens or xenoestrogens may increase breast cancer risk.

  2007cites this paper
• Beyond standard mammographic screening: mammography at age extremes, ultrasound, and MR imaging.

  2007cites this paper
• Screening and Follow-up of the Patient at High Risk for Breast Cancer

  2007cites this paper
• GPCRs IN CANCER The functions and therapeutic value of G-protein-coupled receptors Social and personal aspects of cancer research The mesothelioma epidemic in Turkey CANCER

  2007cites this paper
• Diagnostic Accuracy of the Gail Model in the Black Women’s Health Study

  2007cites this paper
• Raloxifene: A Selective Estrogen Receptor Modulator for Reducing the Risk of Invasive Breast Cancer in Postmenopausal Women

  2007cites this paper
• The tumour microenvironment as a target for chemoprevention

  2007cites this paper
• Future Recommendations Numeric , Verbal , and Visual Formats of Conveying Health Risks : Suggested Best Practices and

  2007cites this paper
• Reducción de riesgo de cáncer de mama: nuevos avances, nuevas preguntas

  2007cites this paper
• Numeric, Verbal, and Visual Formats of Conveying Health Risks: Suggested Best Practices and Future Recommendations

  2007cites this paper
• Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes

  2006cites this paper
• Challenges in Monitoring the Breast Cancer Prevention Trial

  2006cites this paper
• The future of women of minority race/ethnicity in breast cancer chemoprevention therapy.

  2006cites this paper
• Prospective breast cancer risk prediction model for women undergoing screening mammography.

  2006cites this paper